24 January 2013
A study published this last week in the Journal of Cell Biology reports that researchers have uncovered a molecular pathway that contributes to triple-negative breast cancer, a deadly and treatment resistant form of cancer that often occurs in young women. And more yet, vitamin D might be involved in this molecular pathway. A molecular pathway is a series of actions among molecules in a cell that lead to a change in that cell.
Lead author Susan Gonzalo, PhD, Assistant Professor of Biochemistry and Molecular Biology at Saint Louis University and colleagues also identified vitamin D as a possible new cancer therapy, in addition to discovering three biomarkers that will help identify patients who may benefit from the new treatment.